+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Thyroid diseases and cerebrovascular disease



Thyroid diseases and cerebrovascular disease



Stroke 36(10): 2302-2310



Acute cerebral ischemia has been described in different diseases of the thyroid gland, and not only as a result of thyrotoxic atrial fibrillation and cardioembolic stroke. The purpose of this review is to summarize the studies on the relationship between thyroid diseases and cerebrovascular diseases, discussing the main findings for overt hyperthyroidism and hypothyroidism, as well as for subclinical thyroid dysfunction. In overt hyperthyroidism, cardioembolic stroke is clearly associated to thyrotoxic atrial fibrillation, and in subclinical hyperthyroidism with serum thyroid-stimulating hormone levels <0.1 mU/L, the incidence of atrial fibrillation is increased. Although in vitro and in vivo studies indicate a hypercoagulability state in hyperthyroidism, there is insufficient evidence to prove that this state leads to an increased risk of cardiac emboli. However, the hypothesis that overt hyperthyroidism may cause acute cerebral venous thrombosis is intriguing. Possible associations between hyperthyroidism and Moyamoya or Giant cell arteritis have only been described in case reports. There is enough evidence that overt hypothyroidism is associated with several traditional and newer atherosclerotic risk factors, especially hypertension, hyperlipidemia, and hyperhomocysteinemia. For subclinical hypothyroidism, these associations are less certain. Hypothyroidism has been associated with signs of aortic or coronary atherosclerosis, but no case-control or cohort studies have ever investigated hypothyroidism as a possible risk factor for atherothrombotic stroke. Hyperthyroidism is associated with atrial fibrillation and cardioembolic stroke. Hypothyroidism is associated with a worse cardiovascular risk factor profile and leads to progression of atherosclerosis. Associations between hyperthyroidism and acute cerebral venous thrombosis, Moyamoya, and Giant cell arteritis have been suggested, but sound evidence is lacking. Additional studies are needed to clarify these issues.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 012693847

Download citation: RISBibTeXText

PMID: 16179578

DOI: 10.1161/01.str.0000181772.78492.07


Related references

Examination of Changes in Cerebrovascular Diseases in Japan. 4. Changes in Patients with Cerebrovascular Diseases and Associated Disease Changes. Naika. Internal Medicine 15: 357-362, 1965

Edema of cerebrovascular diseases. (5) Medical management of cerebral edema in patients with cerebrovascular disease. Rinsho Shinkeigaku 19(12): 862-863, 1979

Diagnosis and treatment of diseases related to asymptomatic cerebrovascular diseases. 4. Chronic cerebrovascular insufficiency. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 86(5): 808-812, 1997

Diagnosis and treatment of diseases related to asymptomatic cerebrovascular diseases. 3. Binswanger disease. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 86(5): 803-807, 1997

Diagnosis and treatment of diseases related to asymptomatic cerebrovascular diseases. 2. Cerebrovascular dementia. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 86(5): 797-802, 1997

Incidental thyroid carcinoma diagnosed after total thyroidectomy for benign thyroid diseases: incidence and association with thyroid disease type and laboratory markers. International Journal of Endocrinology 2013: 451959, 2013

Thyroid disease as a risk factor for cerebrovascular disease. Journal of Stroke and Cerebrovascular Diseases 24(5): 912-920, 2015

Effects of bypass on CO2 cerebrovascular reactivity in ischaemic cerebrovascular diseases - Based on the intra-operative LCBF and CO2 cerebrovascular reactivity studies. Acta Neurochirurgica 141(4): 369-375, 1999

Serum thyroid-stimulating hormone in cerebrovascular disease. Acta Medica Scandinavica 219(1): 53-58, 1986

Classification of the cerebrovascular diseases. Iberoamerican Cerebrovascular diseases Society. Revista de Neurologia 33(5): 455-464, 2001

Epidemiological evaluation of funduscopic findings in cerebrovascular diseases. I. Fundoscopic findings as risk factors for cerebrovascular diseases. Japanese Circulation Journal 39(3): 257-269, 1975

Internal medicine and neurological disease: progress in diagnosis and treatment. Topics: IV. Chronic kidney disease (CKD) and cerebrovascular diseases. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 101(8): 2195-2203, 2012

Significance of circulating anti thyroid stimulating hormone tsh receptor antibodies in patients with autoimmune thyroid diseases thyroid stimulation blocking antibody in patients with graves' disease. Journal of UOEH 11(4): 393-402, 1989